AstraZeneca's Three-in-One COPD Inhaler Succeeds in Phase III Trial Post author:Sam Post published:January 25, 2018 Post category:BioPharma Astra has Glaxo and its COPD treatment Trelegy Ellipta squarely in its sights. Source: BioSpace You Might Also Like Genetic Tech Exploring Strategic Alternatives August 24, 2017 Abivax First-Half 2017 Financial Results And Update September 21, 2017 Social Media Rumors of Juno Acquisition Cause Stock Jitters January 24, 2017
